Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Consulting agrmnt
Director departure
Appointed director
|
|
180 Life Sciences Corp. (KBLM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/23/2020 |
8-K
| Resignation/termination of a director |
| 11/12/2020 |
8-K
| Amended existing or entered into new employment agreement with an officer, Entered into consulting agreement, Resignation/termination of a director|
Docs:
|
"Second Amended and Restated Certificate of Incorporation of the registrant",
"Form of Lock-Up Agreement",
"Escrow Agreement by and between the registrant, Continental Stock Transfer & Trust Company, and Lawrence Pemble",
"2020 Omnibus Incentive Plan",
"Employment Agreement, by and between 180 Life Corp. (f/k/a 180 Life Sciences Corp.) and James N. Woody, M.D., Ph.D",
"First Amendment to Employment Agreement by and between 180 Life Corp. (f/k/a 180 Life Sciences Corp.) and James N. Woody, M.D., Ph.D",
"Audited financial statements of 180 for the fiscal year ended December 31, 2019 and for the period from March 7, 2018 (Inception) through December 31, 2018",
"Unaudited financial statements of 180 for the six months ended June 30, 2020 and 2019",
"Audited financial statements of CannBioRex Pharmaceuticals Corp. for the period from March 8, 2018 (Inception) through December 31, 2018",
"Unaudited financial statements of CannBioRex Pharmaceuticals Corp. for the six months ended June 30, 2019 and for the period from March 8, 2018 (Inception) through June 30, 2018" |
|
|
|